Comparison of prognostic usefulness of serum insulin-like growth factor-binding protein 7 in patients with heart failure and preserved vs reduced left ventricular ejection fraction
The American Journal of Cardiology Mar 21, 2018
Hage C, et al. - The role of insulin-like growth factor-binding protein 7 (IGFBP-7) in heart failure (HF) pathophysiology was characterized herein. Researchers noted that IGFBP-7 was elevated in patients with HFrEF. In these subjects, IGFBP-7 showed an association with HF severity but not prognosis, suggesting a marker of risk. On the contrary, patients with HFpEF exhibited less elevated IGFBP-7 and its association with markers of diastolic dysfunction, HF severity, and prognosis. Possibly via inflammation and oxidative stress, IGFBP-7 may contribute to progression of HFpEF.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries